Smith Group Asset Management LLC Has $317,000 Stake in DaVita Inc. (NYSE:DVA)

Smith Group Asset Management LLC lessened its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 67.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,070 shares of the company's stock after selling 4,300 shares during the period. Smith Group Asset Management LLC's holdings in DaVita were worth $317,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in DVA. Vontobel Holding Ltd. boosted its holdings in DaVita by 17.8% in the 1st quarter. Vontobel Holding Ltd. now owns 2,464 shares of the company's stock worth $377,000 after acquiring an additional 372 shares during the period. Rovin Capital UT ADV acquired a new position in shares of DaVita during the first quarter worth $18,442,000. Mather Group LLC. grew its holdings in DaVita by 7.0% during the 1st quarter. Mather Group LLC. now owns 1,201 shares of the company's stock valued at $184,000 after purchasing an additional 79 shares in the last quarter. Beaton Management Co. Inc. purchased a new stake in DaVita during the 1st quarter worth $229,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in DaVita by 291.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,388 shares of the company's stock worth $3,664,000 after buying an additional 18,164 shares in the last quarter. Institutional investors and hedge funds own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on DVA shares. Truist Financial dropped their target price on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research report on Monday, May 19th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, DaVita presently has a consensus rating of "Hold" and an average target price of $164.50.

DaVita Price Performance

Shares of NYSE:DVA traded up $4.32 on Tuesday, reaching $146.77. 1,234,882 shares of the company traded hands, compared to its average volume of 807,948. The stock has a market capitalization of $11.08 billion, a PE ratio of 14.55, a P/E/G ratio of 0.98 and a beta of 1.11. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The company's 50 day moving average is $139.64 and its 200-day moving average is $149.38. DaVita Inc. has a fifty-two week low of $131.76 and a fifty-two week high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The firm had revenue of $3.22 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the previous year, the company posted $2.26 EPS. The company's quarterly revenue was up 5.0% compared to the same quarter last year. As a group, analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.